SHANGHAI, CHINA -- (MARKET WIRE) -- April 30, 2007 -- SinoBiomed Inc. ("SinoBiomed", "the Company") (OTCBB: SOBM) is pleased to announce that Dr. Dicken Shiu-Chung Ko, B.SC, M.D., F.R.C.S.C., F.A.C.S, has joined SinoBiomed's Advisory Board. Highly regarded globally for his involvement in developing new medical therapies and techniques, Dr. Ko has over the past decade served as a consultant to leading biomedical device and pharmaceutical companies. He is currently the Surgical Director of the Renal Transplant Program at Massachusetts General Hospital (MGH), a teaching hospital of Harvard Medical School in Boston.
